Literature DB >> 28183400

Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators.

Patryk Łakuta1, Hanna Przybyła-Basista2.   

Abstract

OBJECTIVE: To determine how and under which conditions psoriasis is related to the psychological impairments, in particular, to social anxiety and depression, the current study tested the interplay of selected factors such as gender, age of onset of psoriasis, cognitive and affective elements of body image, experiences of stigmatization, and patients' subjective perceptions of severity of the disease.
METHODS: Adult psoriasis patients (N=193) completed the Appearance Schemas Inventory-Revised, the Stigmatization Scale, the Body Emotions Scale, the Beck Depression Inventory, and the Social Anxiety Questionnaire. The disease severity was defined based on the Body Surface Area (BSA) index.
RESULTS: The effect of psoriasis on social anxiety was moderated by age of onset: higher severity of the disease was associated with higher levels of social anxiety, but only for patients with pre-adult onset psoriasis. Hierarchical multiple regressions revealed that in patients with adult-onset (≥18years of age) the importance of appearance to one's sense of self-worth was the main contributor to social anxiety, while in patients with pre-adult onset, social anxiety was most strongly related to experiences of stigmatization. Moreover, the results indicated that negative body-related emotions mediated the relationship between severity of the disease and depression. Additionally, the relationship between severity of psoriasis and body image emotions was moderated by gender.
CONCLUSIONS: Findings significantly extend previous studies by confirming and highlighting the role of age of onset of psoriasis in psychological impairments, and provide more insight into factors that contribute to social anxiety in this group of patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age of onset; Body image; Depression; Psoriasis; Social anxiety; Stigmatization

Mesh:

Year:  2017        PMID: 28183400     DOI: 10.1016/j.jpsychores.2017.01.007

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  16 in total

1.  Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis.

Authors:  Isabelle Jalenques; Fabien Bourlot; Elisa Martinez; Bruno Pereira; Michel D'Incan; Sophie Lauron; Fabien Rondepierre
Journal:  Acta Derm Venereol       Date:  2022-08-26       Impact factor: 3.875

2.  The Effects of Interacting With a Paro Robot After a Stressor in Patients With Psoriasis: A Randomised Pilot Study.

Authors:  Mikaela Law; Paul Jarrett; Michel K Nieuwoudt; Hannah Holtkamp; Cannon Giglio; Elizabeth Broadbent
Journal:  Front Psychol       Date:  2022-05-12

3.  Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study.

Authors:  Ennio Lubrano; Andrea Delle Sedie; Marco Romanelli; Maria Sole Chimenti; Luca Bianchi; Stefano Piaserico; Catia De Felice; Dario Graceffa; Maria Ilenia De Andres; Salvatore Curatolo; Rosa Daniela Grembiale; Stefano Dastoli; Chiara Arcuri; Rosa Giuseppa Angileri; Francesca Prignano; Francesca Bandinelli; Elena Baldissera; Santo Raffaele Mercuri; Chiara Franchi; Matteo Longhi; Angela Patrì; Francesco Caso; Giuseppe Passiu; Maria Antonia Montesu; Simone Parisi; Elena Stroppiana; Genoveffa Scotto di Luzio; Giovanni Italiano; Sergio Di Nuzzo; Daniele Santilli; Laura Bigi; Federica Lumetti; Concetto Paolo Agnusdei; Maria Grazia Ferrucci; Giuliana Gualberti; Francesca Marando; Roberta Ramonda; Francesco Cusano
Journal:  Clin Rheumatol       Date:  2020-11-06       Impact factor: 2.980

4.  Physiological and behavioral reactivity to social exclusion: a functional infrared thermal imaging study in patients with psoriasis.

Authors:  Giorgia Ponsi; Bianca Monachesi; Vincenzo Panasiti; Salvatore Maria Aglioti; Maria Serena Panasiti
Journal:  J Neurophysiol       Date:  2018-10-31       Impact factor: 2.714

5.  Evaluation of Social Anxiety Levels and Related Factors in Psoriasis Patients: A Controlled, Cross-Sectional Study.

Authors:  Fatma Elif Yildirim; Sıla Şeremet; Fatma Şule Afşar; İrem Yildiz; Esin İyidoğan
Journal:  Noro Psikiyatr Ars       Date:  2020-01-27       Impact factor: 1.339

6.  Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Authors:  Marina Talamonti; Giovanna Malara; Ylenia Natalini; Federico Bardazzi; Andrea Conti; Andrea Chiricozzi; Cristina Mugheddu; Paolo Gisondi; Stefano Piaserico; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Franca Cantoresi; Maria Concetta Fargnoli; Anna Balato; Francesco Loconsole; Annamaria Offidani; Claudio Bonifati; Francesca Prignano; Marta Bartezaghi; Alice Rausa; Elisabetta Aloisi; Roberto Orsenigo; Antonio Costanzo
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

7.  Correlation Between Quality of Life and Depression Among Persons Suffering from Psoriasis.

Authors:  Jasmina Mahmutovic; Mufida Zukic; Arzija Pasalic; Suada Brankovic; Amila Jaganjac; Bakir Katana
Journal:  Med Arch       Date:  2017-10

8.  Anxiety sensitivity and social anxiety in adults with psychodermatological symptoms.

Authors:  Lauren Ellison; Sara M Witcraft; Laura J Dixon
Journal:  Arch Dermatol Res       Date:  2020-08-28       Impact factor: 3.017

9.  Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.

Authors:  Jördis Maria Zill; Jörg Dirmaier; Martin Härter; Ulrich Mrowietz; Matthias Augustin; Sarah Dwinger; Eva Christalle
Journal:  JMIR Res Protoc       Date:  2018-02-07

Review 10.  The psychosocial adaptation of patients with skin disease: a scoping review.

Authors:  Xiu-Jie Zhang; Ai-Ping Wang; Tie-Ying Shi; Jun Zhang; Hui Xu; Da-Qiu Wang; Li Feng
Journal:  BMC Public Health       Date:  2019-10-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.